friday glp 1 Fridays GLP-1 Review: All-Inclusive, BBB Gaps in 2026 Fridays (@joinfridays) • Facebook

Jones Professor of Gerontology at the USC Leonard Davis School

This dual oversight allows both teams to monitor liver function tests, metabolic markers, and gastrointestinal tolerance simultaneously rather than in silos

In November 2023, a new GLP-1, called tirzepatide (Zepbound, Mounjaro), was approved for weight loss and obesity management

But as he studied the poster, he noticed another scientista researcher from Eli Lillyalso taking careful notes

Some easy messaging shifts include: From low-calorie to nutrient-packed From control cravings to support your journey From guilt-free to made to feel good This new class of drugs isnt a fad or a trend, says IFF, which has developed a series of consumer personas of GLP-1 users with distinct values, health goals and emotional drivers

From a more general point of view, it is particularly interesting that these drugs exert their therapeutic action by acting on the brain to reduce appetite and thus create a significant caloric deficit